Maravai LifeSciences Holdings Inc (NASDAQ: MRVI) is 4.22% higher on its value in year-to-date trading and has touched a low of $4.28 and a high of $11.56 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The MRVI stock was last observed hovering at around $5.49 in the last trading session, with the day’s gains setting it 0.19%.
Currently trading at $5.68, the stock is 3.21% and -3.71% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.21 million and changing 3.46% at the moment leaves the stock -28.07% off its SMA200. MRVI registered -10.41% loss for a year compared to 6-month loss of -18.74%. The firm has a 50-day simple moving average (SMA 50) of $5.8987 and a 200-day simple moving average (SMA200) of $7.89625.
The stock witnessed a 5.19% gain in the last 1 month and extending the period to 3 months gives it a -25.85%, and is 1.25% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.21% over the week and 6.28% over the month.
Maravai LifeSciences Holdings Inc (MRVI) has around 650 employees, a market worth around $1.48B and $276.92M in sales. Profit margin for the company is -81.13%. Distance from 52-week low is 32.87% and -50.84% from its 52-week high. The company has generated returns on investments over the last 12 months (-25.16%).
The EPS is expected to shrink by -368.32% this year.
Maravai LifeSciences Holdings Inc (MRVI) Top Institutional Holders
307.0 institutions hold shares in Maravai LifeSciences Holdings Inc (MRVI), with institutional investors hold 104.42% of the company’s shares. The shares outstanding are 141.59M, and float is at 117.45M with Short Float at 7.06%. Institutions hold 102.90% of the Float.
The top institutional shareholder in the company is GTCR LLC with over 20.15 million shares valued at $144.27 million. The investor’s holdings represent 15.2267% of the MRVI Shares outstanding. As of 2024-06-30, the second largest holder is 12 WEST CAPITAL MANAGEMENT LP with 13.21 million shares valued at $94.59 million to account for 9.9833 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 10.75 million shares representing 8.1224% and valued at over $76.96 million, while BLACKROCK INC. holds 7.3519 of the shares totaling 9.73 million with a market value of $69.66 million.
Maravai LifeSciences Holdings Inc (MRVI) Insider Activity
The most recent transaction is an insider purchase by DeFord John A, the company’s Director. SEC filings show that DeFord John A bought 17,500 shares of the company’s common stock on Nov 12 ’24 at a price of $5.75 per share for a total of $0.1 million. Following the purchase, the insider now owns 70046.0 shares.
Maravai LifeSciences Holdings Inc disclosed in a document filed with the SEC on Nov 11 ’24 that HULL CARLbought a total of 175,000 shares of the company’s common stock. The trade occurred on Nov 11 ’24 and was made at $5.64 per share for $0.99 million. Following the transaction, the insider now directly holds 0.17 million shares of the MRVI stock.
Still, SEC filings show that on May 28 ’24, GTCR INVESTMENT XI LLC (Director) disposed off 9,940,974 shares at an average price of $9.81 for $97.57 million. The insider now directly holds 20,150,005 shares of Maravai LifeSciences Holdings Inc (MRVI).
